Logo

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

15.06.2025 12:05

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

June 9, 2025 3:11 pm ET

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has ap… [+11553 chars]

RAHWAY, N.J.--(BUSINESS WIRE)--

Ok, so this is a question seeking an answer to clear up whatever gymnastics are in my head. I'm a moderately attractive guy, sincere heart, genuinely looking to love another, established. Why don't women that I'm attracted to, want me back?